Home » Topics » Regulatory » Patents

Patents
RSS

Progen patents new fusion proteins for allergic diseases

Jan. 29, 2021

Sapience Therapeutics divulges BCL9 mimetic peptides for cancer

Jan. 29, 2021

Idorsia Pharmaceuticals presents IDO1 and TDO inhibitors

Jan. 29, 2021

ChemoCentryx synthesizes new PD-1/PD-L1 interaction inhibitors

Jan. 29, 2021

Sunshine Lake Pharma patents SGLT-1 inhibitors

Jan. 29, 2021

Merck KGaA patents TLR antagonists

Jan. 28, 2021

Chinese investigators describe new KRAS mutant inhibitors

Jan. 28, 2021

Nuvation Bio identifies new BET inhibitors

Jan. 28, 2021

Suzhou Kintor Pharmaceuticals patents c-MYC inhibitors

Jan. 28, 2021

IMPACT Therapeutics presents ATM kinase inhibitors

Jan. 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...